While experimental approaches targeting a single factor (e.g., Spp1 or gal-3) will advance our knowledge on how they individually contribute to muscle fibrosis, resetting the transcriptional program of gal-3+ macrophages to its homeostatic state is likely a more effective therapeutic strategy for DMD. This evidence concerns the gene SPP1 and Duchenne muscular dystrophy.